Pronađeno: 1-7 / 7 radova

Autori: Giraldo Pilar

>> Prikaži sve rezultate

>> Sve godine

Naslov Long-term efficacy and safety results of taliglucerase alfa through 5 years in adult treatment-naive patients with Gaucher disease (Article)
Autori Zimran Ari Duran Gloria Giraldo Pilar Rosenbaum Hanna Giona Fiorina Petakov Milan S Terreros Munoz Eduardo Eduardo Solorio-Meza Sergio Cooper Peter A Varughese Sheeba Alon Sari Chertkoff Raul 
Info BLOOD CELLS MOLECULES AND DISEASES, (2019), vol. 78 br. , str. 14-21
Projekat Protalix BioTherapeutics; Pfizer
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Long-term safety and efficacy of taliglucerase alfa in pediatric Gaucher disease patients who were treatment-naive or previously treated with imiglucerase (Article)
Autori Zimran Ari Gonzalez-Rodriguez Derlis Emilio Abrahamov Aya Cooper Peter A Varughese Sheeba Giraldo Pilar Petakov Milan S Tan Ee Shien Chertkoff Raul 
Info BLOOD CELLS MOLECULES AND DISEASES, (2018), vol. 68 br. , str. 163-172
Projekat Protalix BioTherapeutics; Pfizer
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase (Article)
Autori Pastores Gregory M Shankar Suma P Petakov Milan S Giraldo Pilar Rosenbaum Hanna Amato Dominick J Szer Jeffrey Chertkoff Raul Brill-Almon Einat Zimran Ari 
Info AMERICAN JOURNAL OF HEMATOLOGY, (2016), vol. 91 br. 7, str. 661-665
Projekat Protalix BioTherapeutics; Pfizer
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-naive patients with Gaucher disease (Article)
Autori Zimran Ari Duran Gloria Mehta Atul Giraldo Pilar Rosenbaum Hanna Giona Fiorina Amato Dominick J Petakov Milan S Munoz Eduardo Terreros Solorio-Meza Sergio Eduardo Cooper Peter A Varughese Sheeba Chertkoff Raul Brill-Almon Einat 
Info AMERICAN JOURNAL OF HEMATOLOGY, (2016), vol. 91 br. 7, str. 656-660
Projekat Protalix BioTherapeutics; Pfizer
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase (Article)
Autori Pastores Gregory M Petakov Milan S Giraldo Pilar Rosenbaum Hanna Szer Jeffrey Deegan Patrick B Amato Dominick J Mengel Eugen Tan Ee Shien Chertkoff Raul Brill-Almon Einat Zimran Ari 
Info BLOOD CELLS MOLECULES AND DISEASES, (2014), vol. 53 br. 4, str. 253-260
Projekat Protalix BioTherapeutics; Pfizer
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov The cognitive profile of type 1 Gaucher disease patients (Article)
Autori Biegstraaten Marieke Wesnes Keith A Luzy Cecile Petakov Milan S Mrsic Mirando Niederau Claus Giraldo Pilar Hughes Derralyn Mehta Atul Mengel Karl-Eugen Hollak Carla EM Marodi Laszlo van Schaik Ivo N 
Info JOURNAL OF INHERITED METABOLIC DISEASE, (2012), vol. 35 br. 6, str. 1093-1099
Projekat Actelion [TAMOP 4.2.1./B-09/1/KONV-2010-0007, TAMOP 4.2.2-08/1-2008-0015]; Actelion Pharmaceuticals Ltd, Allschwil, Switzerland; European Working Group on Gaucher Disease (EWGGD)
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study (Article)
Autori Biegstraaten Marieke Mengel Eugen Marodi Laszlo Petakov Milan S Niederau Claus Giraldo Pilar Hughes Derralyn Mrsic Mirando Mehta Atul Hollak Carla EM van Schaik Ivo N 
Info BRAIN, (2010), vol. 133 br. , str. 2909-2919
Projekat European Working Group on Gaucher Disease (EWGGD) ; Actelion Pharmaceuticals Ltd ; Actelion Pharmaceuticals Ltd, Allschwil, Switzerland
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
>> Sve godine

Ispis zapisa u formatu:TXT | BibTeX